Annals of Oncology

News:

Not all the holes are the same: USDA rules on Emmentaler
Ann Oncol 12: 279.
[PDF] [Request Permissions]

Alternative medicine or unproven methods?
Ann Oncol 12: 279.
[PDF] [Request Permissions]

Errare humanum est, perseverare diabolicum
Ann Oncol 12: 279-280.
[PDF] [Request Permissions]

Deadly and toxic waste? Or intoxication by wastebasket papers?
Ann Oncol 12: 280.
[PDF] [Request Permissions]

Italy, the pain is over
Ann Oncol 12: 280.
[PDF] [Request Permissions]

US NCI directorship in the new presidential era
Ann Oncol 12: 280.
[PDF] [Request Permissions]

Challenge
Ann Oncol 12: 281.
[PDF] [Request Permissions]

Awards, appointments
Ann Oncol 12: 281.
[PDF] [Request Permissions]

Perhaps not everyone knows that...
Ann Oncol 12: 281-283.
[PDF] [Request Permissions]

Book reviews:

G. D. Beretta

Book review
Ann Oncol 12: 284.
[PDF] [Request Permissions]

Editorial:

M. Hidalgo and S. G. Eckhardt

Matrix metalloproteinase inhibitors: How can we optimize their development?
Ann Oncol 12: 285-287.
[PDF] [Request Permissions]

Reviews:

M. Maltoni, O. Nanni, E. Scarpi, D. Rossi, P. Serra, and D. Amadori

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: A systematic review of randomised clinical trials
Ann Oncol 12: 289-300.
[Abstract] [PDF] [Request Permissions]

K. I. Pritchard

The role of hormone replacement therapy in women with a previous diagnosis of breast cancer and a review of possible alternatives
Ann Oncol 12: 301-310.
[Abstract] [PDF] [Request Permissions]

Original articles:

A. Weirich, I. Leuschner, D. Harms, G. M. Vujanic, J. Tröger, U. Abel, N. Graf, D. Schmidt, R. Ludwig, and P. A. Voûte

Clinical impact of histologic subtypes in localized non-anaplastic nephroblastoma treated according to the trial and study SIOP-9/GPOH
Ann Oncol 12: 311-319.
[Abstract] [PDF] [Request Permissions]

M. Lorenz, H. H. Mueller, E. Mattes, H. J. Gassel, T. Junginger, H. D. Saeger, H. Schramm, E. Staib-Sebler, G. Vetter, S. Heinrich, C. H. Köhne, and German Cooperative Group on Liver Metastases (Arbeitsgruppe Lebermetastasen und -tumoren (ALM) in der Chirurgischen Arbeitsgemeinschaft Onkologie)

Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas
Ann Oncol 12: 321-325.
[Abstract] [PDF] [Request Permissions]

C. Bosetti, S. Franceschi, E. Negri, R. Talamini, F. Tomei, and C. La Vecchia

Changing socioeconomic correlates for cancers of the upper digestive tract
Ann Oncol 12: 327-330.
[Abstract] [PDF] [Request Permissions]

S. Franceschi, L. Dal Maso, F. Levi, E. Conti, R. Talamini, and C. La Vecchia

Leanness as early marker of cancer of the oral cavity and pharynx
Ann Oncol 12: 331-336.
[Abstract] [PDF] [Request Permissions]

F. Chiaffarino, C. Pelucchi, F. Parazzini, E. Negri, S. Franceschi, R. Talamini, E. Conti, M. Montella, and C. La Vecchia

Reproductive and hormonal factors and ovarian cancer
Ann Oncol 12: 337-341.
[Abstract] [PDF] [Request Permissions]

C. A. Mantz, E. Vokes, M. S. Kies, B. Mittal, M. E. Witt, M. A. List, R. R. Weichselbaum, and D. J. Haraf

Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer
Ann Oncol 12: 343-347.
[Abstract] [PDF] [Request Permissions]

W. S. Kim, S.-Y. Song, Y. C. Ahn, Y.-H. Ko, C.-H. Baek, D. Y. Kim, S.-S. Yoon, H. G. Lee, W. K. Kang, H. J. Lee, C. H. Park, and K. Park

CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?
Ann Oncol 12: 349-352.
[Abstract] [PDF] [Request Permissions]

D. Crivellari, O. Pagani, A. Veronesi, D. Lombardi, F. Nolè, B. Th{diaeresis}rlimann, D. Hess, M. Borner, J. Bauer, G. Martinelli, R. Graffeo, C. Sessa, A. Goldhirsch, and International Breast Cancer Study Group

High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel
Ann Oncol 12: 353-356.
[Abstract] [PDF] [Request Permissions]

D. ten Bokkel Huinink, M. E. T. Tesselaar, R. J. Baatenburg de Jong, H. P. Verschuur, and H. J. Keizer

A phase I study of a fixed dose of cisplatin with increasing doses of raltitrexed (Tomudex^reg;) in the treatment of patients with locally advanced or metastatic squamous cell carcinoma of the head and neck
Ann Oncol 12: 357-363.
[Abstract] [PDF] [Request Permissions]

P. E. Schofield, L. J. Beeney, J. F. Thompson, P. N. Butow, M. H. N. Tattersall, and S. M. Dunn

Hearing the bad news of a cancer diagnosis: The Australian melanoma patient's perspective
Ann Oncol 12: 365-371.
[Abstract] [PDF] [Request Permissions]

G. Sanguineti, L. Del Mastro, M. Guenzi, P. Ricci, M. Cavallari, G. Canavese, I. Stevani, and M. Venturini

Impact of chemotherapy dose-density on radiotherapy dose-intensity after breast conserving surgery
Ann Oncol 12: 373-378.
[Abstract] [PDF] [Request Permissions]

E. Mercadé, M. Cascalló, M. Carrió, J. Calbó, A. Gómez-Treviño, C. Fillat, A. M. Gómez-Foix, and A. Mazo

Treatment based on a combination of the CYP2B1/cyclophosphamide system and p53 delivery enhances tumour regression in human pancreatic cancer
Ann Oncol 12: 379-388.
[Abstract] [PDF] [Request Permissions]

C. Erlichman, A. A. Adjei, S. R. Alberts, J. A. Sloan, R. M. Goldberg, H. C. Pitot, J. Rubin, P. J. Atherton, G. G. Klee, and R. Humphrey

Phase I study of the matrix metal loproteinase inhibitor, BAY 12–9566
Ann Oncol 12: 389-395.
[Abstract] [PDF] [Request Permissions]

D. Peiffert, M. Giovannini, M. Ducreux, P. Michel, E. François, C. Lemanski, X. Mirabel, F. Cvitkovic, E. Luporsi, T. Conroy, J.-P. Gérard, and Digestive Tumours Group of the French ‘Fédération Nationale des Centres de Lutte Contre le Cancer’

High-dose radiation therapy and neoadjuvant plus concomitant chemotherapy with 5-fluorouracil and cisplatin in patients with locally advanced squamous-cell anal canal cancer: Final results of a phase II study
Ann Oncol 12: 397-404.
[Abstract] [PDF] [Request Permissions]

S. W. Langer, M. Sehested, and P. Buhl Jensen

Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice
Ann Oncol 12: 405-410.
[Abstract] [PDF] [Request Permissions]

Clinical cases:

T. A. Plunkett, A. M. Hanby, D. W. Miles, and R. D. Rubens

Metastatic eccrine porocarcinoma: Response to docetaxel (Taxotere) chemotherapy
Ann Oncol 12: 411-414.
[Abstract] [PDF] [Request Permissions]

C. Lerchenmüller, M. Göner, T. Büchner, and W. E. Berdel

Rhinocerebral zygomycosis in a patient with acute lymphoblastic leukemia
Ann Oncol 12: 415-419.
[Abstract] [PDF] [Request Permissions]

Letters to the editor:

M. Penz, G. V. Kornek, M. Raderer, H. Ulrich-Pur, W. Fiebiger, and W. Scheithauer

Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy.
Ann Oncol 12: 421-422.
[PDF] [Request Permissions]

I. Cowie and A. Barrett

Uneventful administration of cisplatin to a man with X-linked Charcot-Marie-Tooth disease (CMT)
Ann Oncol 12: 422.
[PDF] [Request Permissions]

Advertisements in this issue:

Advertisements in this issue
Ann Oncol 12: 423-428.
[PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.